Glendale Pharma Private Limited
About Glendale Pharma Private Limited
Data last updated:
Glendale Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the chemical products segment of the chemicals sector. It was incorporated on 13 June 2005.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC153949.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Lilly Tanna and Indravadan Shantilal Tanna.
Its last annual general meeting (AGM) was held on 29 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at 19 – B – 1 Takshila Societymahakali Caves Road Andheri (E), Mumbai, Maharashtra, India – 400093.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address19 – B – 1 Takshila Societymahakali Caves Road Andheri (E), Mumbai, Maharashtra, India – 400093
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Glendale Pharma Private Limited FY 2015 filings available
Financial Statement Summary of Glendale Pharma Private Limited
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Glendale Pharma Private Limited
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glendale Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Glendale Pharma Private Limited
Glendale Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lilly Tanna | Director | 07 May 2007 | 19 Years 5 Months | As last reported |
| Indravadan Shantilal Tanna | Director | 07 May 2007 | 19 Years 5 Months | As last reported |
Charges & Borrowings of Glendale Pharma Private Limited
Glendale Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Glendale Pharma Private Limited
Employment history and EPFO contributions of people linked to Glendale Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glendale Pharma Private Limited
Glendale Pharma Private Limited has 2 board changes on record since 2007: 2 appointments. The latest: Indravadan Shantilal Tanna was appointed as Director on 07 May 2007.
Credit Ratings, Litigation & Regulatory Alerts for Glendale Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glendale Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glendale Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glendale Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glendale Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glendale Pharma Private Limited
Glendale Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Glendale Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in chemical products, within the chemicals industry. It was incorporated on 13 June 2005 and is registered under CIN U24230MH2005PTC153949. The company has been struck off by the Registrar of Companies and is no longer operational.
Glendale Pharma had 2 directors:
- Lilly Tanna - Director
- Indravadan Shantilal Tanna - Director
The CIN (Corporate Identification Number) of Glendale Pharma is U24230MH2005PTC153949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Glendale Pharma is at 19 – B – 1 Takshila Societymahakali Caves Road Andheri E, Mumbai, Maharashtra, India – 400093.
Glendale Pharma was incorporated on 13 June 2005. It is registered with the Registrar of Companies, Mumbai.
Glendale Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Glendale Pharma operated in the chemicals industry, in the chemical products segment. It worked in this industry before it was struck off.
No. Glendale Pharma is not listed on any stock exchange. It is an unlisted company.
Indravadan Shantilal Tanna was appointed as Director on 07 May 2007. Lilly Tanna was appointed as Director on 07 May 2007.